| Income Statement |
| Total Revenue | 82.02M |
|
| Revenues (USD) | 82.02M |
| Cost of Revenue | 20.47M |
| Gross Profit | 61.55M |
| Operating Expenses | 51.50M |
| Research and Development Expense | 3.54M |
| Selling, General and Administrative Expense | 47.95M |
| Operating Income | 10.06M |
| Income Tax Expense | 2.79M |
| Net Income | 11.56M |
| Net Income Common Stock | 11.56M |
| Net Income Common Stock (USD) | 11.56M |
| Consolidated Income | 11.56M |
| Earnings per Basic Share | 0.18 |
| Earnings per Basic Share (USD) | 0.18 |
| Earnings per Diluted Share | 0.18 |
| Earning Before Interest & Taxes (EBIT) | 14.35M |
| Earning Before Interest & Taxes (USD) | 14.35M |
| Weighted Average Shares | 63.40M |
| Weighted Average Shares Diluted | 63.94M |
| Balance Sheet |
| Cash and Equivalents | 394.30M |
| Cash and Equivalents (USD) | 394.30M |
| Investments | 143.56M |
| Investments Current | 142.86M |
| Investments Non-Current | 700.00K |
| Trade and Non-Trade Receivables | 45.91M |
| Current Assets | 680.78M |
| Property, Plant & Equipment Net | 11.23M |
| Total Assets | 750.84M |
| Total Debt | 4.83M |
| Current Liabilities | 77.35M |
| Debt Non-Current | 4.83M |
| Total Liabilities | 89.58M |
| Shareholders Equity | 661.25M |
| Shareholders Equity (USD) | 661.25M |
| Assets Non-Current | 70.06M |
| Total Debt (USD) | 4.83M |
| Deferred Revenue | 19.11M |
| Inventory | 71.41M |
| Liabilities Non-Current | 12.23M |
| Trade and Non-Trade Payables | 16.85M |
| Tax Assets | 52.92M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 175.00K |
| Net Cash Flow from Financing | -32.43M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 91.75M |
| Capital Expenditure | -172.00K |
| Issuance (Purchase) of Equity Shares | -31.24M |
| Net Cash Flow from Investing | 109.10M |
| Net Cash Flow - Investment Acquisitions and Disposals | 109.28M |
| Net Cash Flow from Operations | 15.39M |
| Effect of Exchange Rate Changes on Cash | -311.00K |
| Share Based Compensation | 2.70M |